[VRDN] QoQ Quarter Result on 30-Sep-2018 [#Q3]

Stock
[VRDN] Viridian Therapeutics, Inc.
Announcement Date
07-Nov-2018
Financial Year
2018
Quarter
30-Sep-2018 [#Q3]
Profit Trend
QoQ- -3.41%
YoY- -54.46%
Quarter Report
VRDN's Result
VRDN's Financial Summary
View:
Show?
Quarter Result
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
Revenue 2,514 372 476 944 2,182 4,784 1,192 64.68%
PBT -8,896 -11,629 -10,317 -9,011 -8,714 -4,661 -6,386 24.80%
Tax 204 339 289 362 361 167 77 91.80%
NP -8,896 -11,629 -10,317 -9,011 -8,714 -4,661 -6,386 24.80%
Tax Rate - - - - - - - -
Total Cost 11,410 12,001 10,793 9,955 10,896 9,445 7,578 31.46%
Ratio Analysis
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
NP Margin -353.86 -3,126.08 -2,167.44 -954.56 -399.36 -97.43 -535.74 -24.21%
Per Share
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
EPS -4.31 -5.65 -5.02 -4.40 -4.31 -2.64 -4.30 0.15%
EPS Diluted -4.31 -5.65 -5.02 -4.40 -4.31 -2.64 -4.30 0.15%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.